Thomas Hope
Clinical trials sponsored by Thomas Hope, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New scan could spot hidden cancers better Results expected Dec 2026 (estimated)
- New hope for High-Risk prostate cancer: which targeted radiation works best? Results expected Apr 2027 (estimated)
-
New PET scan spots hidden parathyroid tumors better than standard test?
Diagnosis CompletedThis study tested a special PET scan (18F-fluorocholine) to see if it could better locate overactive parathyroid glands (adenomas) in people with hyperparathyroidism. 139 participants received the scan before surgery, and the results were compared to standard imaging and the actu…
Phase 3 • Sponsor: Thomas Hope • Aim: Diagnosis
Last updated Jun 27, 2026 12:25 UTC
-
New dye could sharpen PET scans for recurrent brain cancer
Diagnosis CompletedThis study tested whether a special dye called fluoroethyltyrosine (FET) can improve PET scans for detecting brain tumors that have come back. 143 people with suspected recurrent brain tumors received an injection of FET before their PET scan. The goal was to see if FET-PET could…
Phase 2 • Sponsor: Thomas Hope • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC